![Alexandra Bause](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Bause
Fondateur chez Apollo Ventures Holding GmbH
Profil
Alexandra Bause is the founder of Apollo Ventures Holding GmbH.
She is currently working as a Director at Cleara Biotech BV.
Dr. Bause holds a doctorate degree from Harvard University.
Postes actifs de Alexandra Bause
Sociétés | Poste | Début |
---|---|---|
Apollo Ventures Holding GmbH
![]() Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Fondateur | - |
Cleara Biotech BV
![]() Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Directeur/Membre du Conseil | - |
Formation de Alexandra Bause
Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Apollo Ventures Holding GmbH
![]() Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Finance |
Cleara Biotech BV
![]() Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |